Eric Strati, Pharm.D.

Eric Strati, Pharm.D. has extensive experience in the pharmaceutical industry. In 2001, they began their career as a Specialty Sales Consultant at CVS Caremark Corporation. Eric then moved to Bristol-Myers Squibb in 2004 as a Sr. Medical Science Liaison - Immunoscience (Orencia). In 2007, they joined HSBC Securities as a Vice President, Global Pharmaceutical Equity Research Analyst, where they co-led the investment bank position and investment thesis on US large cap pharmaceuticals. In 2009, they became a Clinical Science Manager - Renal/Cardiometabolic at Genzyme. In 2010, they joined Novartis as an Executive Director, Head of Regional Account Management. Eric then held the roles of Head, US Strategic Market Access, Director of Strategic Market Access and Associate Marketing Director. In 2015, they moved to Mesoblast Limited as a Sr. Vice President, Head of Global Commercial, Vice President, Head of Global Commercial and Vice President, Global Pricing & Reimbursement/Market Access. In 2021, they joined Takeda as Vice President, Global Lead GI Cell Therapy (Alofisel). Eric is currently the CEO of Gift of Life Biologics.

Eric Strati, Pharm.D. completed their Bachelor of Pharmacy (B.Pharm.) at Albany College of Pharmacy and Health Sciences. Eric then pursued a Master of Business Administration (M.B.A.) in Health/Health Care Administration/Management at Union College. Finally, they earned their Doctor of Pharmacy (Pharm.D.) from The University of Kansas. Eric is also a Registered Pharmacist in New York.